Sanofi India’s Type 1 Diabetes Social Impact Program with RSSDI delivering positive outcomes
Improved access to care and management resulting in fewer episodes of hypoglycaemia and hyperglycaemia per weekBhubaneswar: Research Society for the Study of Diabetes in India (RSSDI) along with Sanofi India Limited (SIL) have shared!-->…